Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bally Ribbon Mills Offers Custom-Designed Woven Materials for Critical Rigging and Tie Down Applications

    Sep 29, 2022, 12:12 PM by
    Full story
  • Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment

    Sep 29, 2022, 12:00 PM by
    Monon Bioventure receives funding to develop Purdue-discovered glioblastoma treatment
    Full story
  • Samsung Biologics Earns Gold Rating from EcoVadis for Its Sustainability Efforts

    Sep 29, 2022, 11:59 AM by
    Full story
  • New 30-Plex Immuno-Oncology Protein Target Panel, Temple Medicine’s Pulmonary Artery Blood Clot Reduction Device, More

    Sep 29, 2022, 01:00 AM by User Not Found
    Bio-IT World | A cloud-based software solution to streamline flow cytometry workflow; the world’s most extensive repeated set of highly-detailed, multi-organ images from a large cohort of participants; a gene editing therapy for inflammatory cardiac diseases; and more.
    Full story
  • Alfa Chemistry Offers Abundant Choices of Alternative Energy Materials for Energy Storage & Batteries

    Sep 28, 2022, 09:27 AM by
    Full story
  • Quanticate partners with Cancer Research UK to launch DETERMINE Study

    Sep 28, 2022, 09:25 AM by
    Full story
  • Vyasa Adds Real-Time Dashboards to Layar Data Fabric

    Sep 28, 2022, 09:25 AM by
    Vyasa, an innovative provider of highly scalable deep learning A.I. analytics software for healthcare, life sciences and business applications, today introduces its latest application interface, Signal. Featuring an intuitive design, Signal enables users to monitor trends and identify anomalies in their Layar data fabric through highly-visual charts and graphs delivered in a single dashboard.
    Full story
  • Follow the Money: NIH Funds Brain Mapping Network Initiative, Non-Invasive Skin Patch for Vaccine Delivery, More

    Sep 28, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funding for multi-omic human brain cell atlas, AI-based drug discovery and development, genomic medicine software simulation platform, and more.
    Full story
  • PacBio Announces New Analysis Method for Tandem Repeats

    Sep 27, 2022, 10:05 AM by User Not Found
    Bio-IT World | PacBio has announced the availability of a new computational analysis method for profiling more than a million tandem repeats across the human genome using PacBio’s native long-read HiFi sequencing data. The Tandem Repeat Genotyping Tool is intended to provide scientists with the ability to obtain a full characterization of the sequence and methylation status of tandem repeats genome-wide.
    Full story
  • Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug

    Sep 27, 2022, 09:33 AM by
    Full story
  • Integrated DNA Technologies Launches New PrimeTime™ qPCR One-Step Master Mix with Exclusive Mutant Enzyme

    Sep 27, 2022, 09:31 AM by
    Full story
  • BioIVT Acquires Fidelis Research

    Sep 27, 2022, 09:31 AM by
    This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.
    Full story
  • State of the Industry: Checking in on AI Trends and Progress with Fernanda Foertter

    Sep 27, 2022, 01:00 AM by User Not Found
    Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, host Stan Gloss, founder of BioTeam, gets an update from Fernanda Foertter, Voltron Data, about her AI experiences in the past few years and whether we’ve made any real progress.
    Full story
  • Abzena strengthens R&D capabilities to support rapid antibody discovery

    Sep 23, 2022, 10:29 AM by
    For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.
    Full story
  • Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

    Sep 23, 2022, 10:24 AM by
    Full story
  • Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

    Sep 23, 2022, 10:24 AM by
    Full story
  • CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

    Sep 23, 2022, 10:17 AM by
    Full story
  • DDA Platform Offers A Wide Range of in Vitro and in Vivo Assays to Cover Early Stage Drug Discovery

    Sep 23, 2022, 10:14 AM by
    Full story
  • Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

    Sep 23, 2022, 10:10 AM by
    Full story
  • Creative Bioarray Designs Comprehensive Tools and Protocols to Construct Animal Disease Models

    Sep 23, 2022, 10:10 AM by
    Full story
  • «
  • 111
  • 112
  • 113
  • 114 (current)
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy